Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
CapsoVision, Inc. (CV) is a company in the Health care sector; its shares trade on Nasdaq.
The price of CapsoVision, Inc. (CV) on October 30, 2026 is 6.85 $, −1.30 % on the day. Over 52 weeks the stock traded between 4.50 $ and 15.37 $; the price now sits 22 % of the way up that range. Over the past year the price changed by +41.65 %. Market capitalization is 168.36 million $, rank 9 among 20 stocks of the same industry with a known capitalization.
CapsoVision, Inc. trades on Nasdaq under the ticker CV. The company belongs to the Health care sector. The trading history on this page starts on 2 July 2025.
Over the past 52 weeks CV has traded between 4.50 $ and 15.37 $. As of 30 October 2026 the price stood 18.68 % of the way from the 52-week low to the high.
Over one year CV shares rose 41.65 %; over six months they rose 8.65 %. Volatility over 90 days is 64.66 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 12.1, above the sector median of 3.6. Price to book is 12.8, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
CapsoVision, Inc. reported revenue of 14M $ and a net loss of 30M $ over the last four quarters. Net margin is −214.74 %. Revenue changed by +10.99 % year over year. Earnings per share are 3.16 $. Market capitalisation is 168M $.
CV has a return on equity of −226.56 %, below the sector median of −40.58 %. Return on assets is −160.64 %, below the sector median of −30.08 %. Operating margin is −217.09 %, below the sector median of −20.96 %.